New Strong Sell Stocks for Oct. 17th

Group 1 - Gyre Therapeutics, Inc. (GYRE) is focused on organ fibrosis and inflammatory diseases, with a Zacks Consensus Estimate for its current year earnings revised downward by almost 69.1% over the last 60 days [1] - Darling Ingredients (DAR) provides rendering, cooking oil, and bakery waste recycling and recovery solutions, with its current year earnings estimate revised downward by 21.7% over the last 60 days [2] - Cresco Labs Inc. (CRLBF) is an integrated multistate cannabis operator in the United States, with a Zacks Consensus Estimate for its current year earnings revised downward by almost 9.1% over the last 60 days [2]